Related Experiment Video
Updated: Oct 30, 2025
08:19
Transfer of Manipulated Tumor-associated Neutrophils into Tumor-Bearing Mice to Study their Angiogenic Potential In Vivo
Published on: July 20, 2019
6.1K
Nitric Oxide Modulates Metabolic Processes in the Tumor Immune Microenvironment
Christopher L McGinity1, Erika M Palmieri1, Veena Somasundaram1
1Laboratory of Cancer ImmunoMetabolism, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Frederick, MD 21702, USA.
International Journal of Molecular Sciences
|July 2, 2021
Summary
Cancer cells exhibit diverse metabolic needs and functions, leading to metabolic heterogeneity within tumors. Understanding these metabolic pathways and their interactions is crucial for predicting clinical outcomes and developing effective cancer therapies.
Area of Science:
- Oncology
- Cancer Biology
- Tumor Microenvironment
Background:
- Cancer cells have distinct metabolic requirements compared to normal tissues.
- Tumor growth leads to distorted vasculature, causing hypoxia and stress.
- Hypoxia and altered metabolic pathways are hallmarks of aggressive, therapy-resistant tumors.
Purpose of the Study:
- To review how biochemical interactions of metabolic pathways influence cancer and immune microenvironments.
- To discuss mechanisms linking metabolic heterogeneity to clinical outcomes.
Main Methods:
- Literature review of recent studies on cancer metabolism.
- Analysis of metabolic pathway alterations in tumors.
- Examination of cell-type-specific metabolic processes and their spatial organization.
Main Results:
- Metabolic processes are not uniform within the tumor microenvironment, exhibiting cell-type specificity.
- Metabolically distinct cells form neighborhoods that communicate via signaling metabolites.
- Metabolic heterogeneity influences tumor behavior and response to therapy.
Conclusions:
- Metabolic heterogeneity within the tumor microenvironment is a key factor in cancer progression and therapeutic response.
- Understanding these complex metabolic interactions is vital for improving clinical outcomes.
Related Concept Videos
01:28Nitric Oxide Signaling Pathway
5.5K
Nitric oxide (NO), an inorganic gas, acts as a potent second messenger in most animal and plant tissues. NO diffuses out of the cells that produce it and enters the neighboring cells to generate a downstream response. NO synthase (NOS) catalyzes NO production by the deamination of the amino acid arginine. There are three isoforms of NOS. Endothelial cells have endothelial NOS (eNOS), nerve and muscle cells have neuronal NOS (nNOS), and macrophages produce inducible NOS (iNOS) upon exposure...
5.5K
02:17The Tumor Microenvironment
7.1K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.1K
01:24Regulation of Angiogenesis and Blood Supply
2.9K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.9K
01:27Tumor Immunotherapy
783
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
783
02:49Cancer Therapies
8.8K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
8.8K
03:03mTOR Signaling and Cancer Progression
4.0K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.0K